VS

Viragonda Subhash Parvate Patil

Active Director Director DIN 08912610
DIN 08912610 First appointment Oct 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Viragonda Subhash Parvate Patil

Data last updated:

Viragonda Subhash Parvate Patil is a Director at Shreesha Life Sciences Private Limited (since 2020). The company operates in Chemicals.

DIN 08912610
Primary Designation Director
Industry Chemicals
First Appointment 10 Oct 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Oct 20202020Active

Board colleagues of Viragonda Subhash Parvate Patil

NameDINCompanyDesignation
Vaibhav Ashok Kadam08912611Shreesha Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shreesha Life Sciences Private Limited
Premium access

Shareholding and investment profile for Viragonda Subhash Parvate Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viragonda Subhash Parvate Patil

Viragonda Subhash Parvate Patil currently holds 1 directorship: Shreesha Life Sciences Private Limited (Director, since 10 Oct 2020).

Viragonda Subhash Parvate Patil was first appointed on 10 Oct 2020 as Director at Shreesha Life Sciences Private Limited.

The current boards of Viragonda Subhash Parvate Patil's companies include Vaibhav Ashok Kadam (Shreesha Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available